ATE536167T1 - Zusammensetzung zur förderung der kollagenproduktion - Google Patents

Zusammensetzung zur förderung der kollagenproduktion

Info

Publication number
ATE536167T1
ATE536167T1 AT04792515T AT04792515T ATE536167T1 AT E536167 T1 ATE536167 T1 AT E536167T1 AT 04792515 T AT04792515 T AT 04792515T AT 04792515 T AT04792515 T AT 04792515T AT E536167 T1 ATE536167 T1 AT E536167T1
Authority
AT
Austria
Prior art keywords
collagen production
promoting collagen
composition
nucleic acid
related substance
Prior art date
Application number
AT04792515T
Other languages
English (en)
Inventor
Shigeo Shinohara
Mitsuaki Kawamura
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE536167T1 publication Critical patent/ATE536167T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT04792515T 2003-10-08 2004-10-08 Zusammensetzung zur förderung der kollagenproduktion ATE536167T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003349156 2003-10-08
PCT/JP2004/015298 WO2005034902A1 (ja) 2003-10-08 2004-10-08 コラーゲン産生促進用組成物

Publications (1)

Publication Number Publication Date
ATE536167T1 true ATE536167T1 (de) 2011-12-15

Family

ID=34430996

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04792515T ATE536167T1 (de) 2003-10-08 2004-10-08 Zusammensetzung zur förderung der kollagenproduktion

Country Status (13)

Country Link
US (1) US7557093B2 (de)
EP (1) EP1671618B1 (de)
JP (2) JP4614886B2 (de)
KR (1) KR20060132817A (de)
CN (1) CN100569213C (de)
AT (1) ATE536167T1 (de)
AU (1) AU2004279248B2 (de)
BR (1) BRPI0415229A (de)
CA (1) CA2541584C (de)
ES (1) ES2376062T3 (de)
HK (1) HK1093891A1 (de)
TW (1) TW200514575A (de)
WO (1) WO2005034902A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006225271A (ja) * 2005-02-15 2006-08-31 Otsuka Pharmaceut Co Ltd シワの予防又は改善剤
EP2174647B1 (de) * 2007-08-06 2017-12-13 Otsuka Pharmaceutical Co., Ltd. Gelartige zusammensetzung zur externen anwendung mit einer adeninverbindung
KR100903654B1 (ko) 2007-10-10 2009-06-18 (주)더페이스샵코리아 하고초 추출물과 아데노신을 함유하는 화장료 조성물
CN101854911B (zh) 2008-06-09 2012-11-28 大塚制药株式会社 外用组合物
WO2011162416A1 (en) 2010-06-25 2011-12-29 Otsuka Pharmaceutical Co., Ltd. Agent for suppressing the formation of abnormal skin cells caused by exposure to light
EP2671565B1 (de) 2011-02-01 2016-09-21 Hayashibara Co., Ltd. Externes präparat für die haut
EP2561869B1 (de) * 2011-02-14 2016-12-14 J-Oil Mills, Inc. Mittel zur förderung der kollagenproduktion durch die haut
JP2013193985A (ja) * 2012-03-19 2013-09-30 Kao Corp 育毛剤
JP6332902B2 (ja) * 2012-10-29 2018-05-30 株式会社ピカソ美化学研究所 美容用組成物
JP2014141475A (ja) * 2012-12-27 2014-08-07 Daiichi Sankyo Co Ltd 新規美白剤
KR101507224B1 (ko) * 2013-05-29 2015-03-30 부산대학교 산학협력단 마늘 유래 우라실을 유효성분으로 함유하는 주름 개선용 조성물
WO2015066194A1 (en) 2013-10-29 2015-05-07 Mary Kay Inc. Cosmetic compositions
WO2018147385A1 (ja) 2017-02-08 2018-08-16 オリエンタル酵母工業株式会社 皮膚色素沈着抑制剤
KR20200031665A (ko) 2017-07-24 2020-03-24 오츠카 세이야쿠 가부시키가이샤 외용 조성물
KR102026365B1 (ko) * 2018-05-11 2019-11-04 주식회사 네이처인랩 우리딘 및 활성촉진 복합체를 포함하는 화장료 조성물
EP4414001A1 (de) 2021-10-07 2024-08-14 Yamasa Corporation Hautpflegezusammensetzung und verwendung davon sowie hautpflegezusammensetzungs-quellmaterial

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266855A (en) 1979-09-24 1981-05-12 Quantor Corporation Quick change lens system
ES507187A0 (es) 1981-11-16 1983-01-01 Union Ind Y Agro Ganader S A U Procedimiento de obtencion de una leche humanizada adiciona-da de nucleotidos con destino a la alimentacion infantil.
ES8503941A1 (es) 1982-10-27 1985-04-16 Crinos Industria Farmaco Procedimiento de obtencion de composiciones para promover el trofismo de la piel y de foliculos piliferosos relacionados
EP0256472A3 (de) 1986-08-11 1988-09-07 Lion Corporation Kosmetische Mittel zur Anwendung auf der Haut
JPS63183535A (ja) * 1986-09-18 1988-07-28 Lion Corp 皮膚外用剤
US5182269A (en) 1987-09-23 1993-01-26 Crinos Industria Farmacobiologica Spa Composition for topical use having hair stimulating, anti-dandruff and anti-seborrhoic activity
JP3818674B2 (ja) * 1992-06-02 2006-09-06 三省製薬株式会社 皮膚外用剤
JPH07233037A (ja) * 1993-12-29 1995-09-05 Sansho Seiyaku Co Ltd 皮膚化粧料
US5602109A (en) 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
JPH09295915A (ja) * 1996-04-26 1997-11-18 Kikkoman Corp 皮膚化粧料
GB9701374D0 (en) 1997-01-23 1997-03-12 Univ Liverpool Purinergic agonists and antagonists
US6203805B1 (en) 1998-11-10 2001-03-20 Color Access, Inc. Topical compositions containing whey proteins
JP2001031549A (ja) * 1999-07-14 2001-02-06 Pola Chem Ind Inc 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料
JP2001278783A (ja) 2000-03-29 2001-10-10 Shiseido Co Ltd コラーゲン産生促進剤
JP3608078B2 (ja) 2000-05-11 2005-01-05 株式会社アルソア本社 コラーゲン産生促進剤、エストロゲン様作用剤、皮膚化粧料および美容食品
US6759033B2 (en) 2000-06-22 2004-07-06 Access Business Group International Llc Method for slowing the decomposition of a cosmetic composition
KR20080070782A (ko) 2001-04-13 2008-07-30 오츠카 세이야쿠 가부시키가이샤 당 흡수 촉진제
DE10132338A1 (de) 2001-07-04 2003-01-16 Basf Ag Verwendung von 5'-Desoxy-5'-methylthioadenosin in hautkosmetischen Mitteln
JP4627988B2 (ja) * 2002-04-09 2011-02-09 大塚製薬株式会社 細胞増殖用組成物

Also Published As

Publication number Publication date
AU2004279248A1 (en) 2005-04-21
JPWO2005034902A1 (ja) 2006-12-21
EP1671618B1 (de) 2011-12-07
WO2005034902A1 (ja) 2005-04-21
CN100569213C (zh) 2009-12-16
KR20060132817A (ko) 2006-12-22
EP1671618A4 (de) 2009-11-11
CA2541584A1 (en) 2005-04-21
TWI347846B (de) 2011-09-01
AU2004279248B2 (en) 2011-05-12
CN1867316A (zh) 2006-11-22
US20070135374A1 (en) 2007-06-14
EP1671618A1 (de) 2006-06-21
US7557093B2 (en) 2009-07-07
JP2010215648A (ja) 2010-09-30
JP4614886B2 (ja) 2011-01-19
BRPI0415229A (pt) 2006-12-05
CA2541584C (en) 2013-02-26
HK1093891A1 (en) 2007-03-16
ES2376062T3 (es) 2012-03-08
TW200514575A (en) 2005-05-01

Similar Documents

Publication Publication Date Title
HK1093891A1 (en) Composition for promoting collagen production
DE602004021585D1 (de) 5,7-DIAMINOPYRAZOLOi4,3-D PYRIMIDINE ZUR VERWENDUNG IN DER BEHANDLUNG VON BLUTHOCHDRUCK
WO2007024899A3 (en) Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes
DE602005004139D1 (de) Verwendung von Salicyloyl-Sphingoidbase zur Behandlung oder Verhinderung von Cellilitis
DK1545587T3 (da) Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
AR074161A1 (es) Una calcomania de tatuaje temporal para aplicar enla piel de un usuario y configurada para detectar la presencia de un analito y metodo para detectar la presencia de un analito
ATE333863T1 (de) Zusammensetzungen enthaltend ein ethanolaminderivat sowie organische metallsalze
EP1498101A4 (de) Zusammensetzung für zellproliferation
ATE503454T1 (de) Kosmetische zusammensetzungen und verfahren zu ihrer verwendung zur verbesserung des ästhetischen erscheinungsbilds der haut
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
DE50107916D1 (de) Dreidimensionales hautmodell
EP2298275A4 (de) Zusammensetzung zur topischen anwendung
TW200719920A (en) Topical skin care composition
DE60335018D1 (de) Mittel zur verhinderung von hautalterung
WO2007092796A3 (en) Galvanic current skin treatment
ATE527377T1 (de) Erstellung von genexpressionprofilen aus ffpe- proben
NO20091517L (no) Emulsjon
WO2005000224A3 (en) Novel dermatological composition
WO2005102363A3 (en) Methods of promoting cartilage healing or cartilage integration
TW200704407A (en) Composition and method for promoting hair growth
ATE363888T1 (de) Verwendung von adenosin oder einem adenosinanalogen zur glättung von feinen linien
WO2005040339A3 (en) Aptamers to human epidermal growth factor receptor-3
BRPI0411168B1 (pt) Composição para o tratamento dos cabelos, usos da composição e método de tratamento dos cabelos.
ATE519479T1 (de) Kosmetikum mit anti-alterungswirkung